Clinical investigator financial disclosure final rule sets $25,000 payment, $50,000 equity threshold.
This article was originally published in The Gray Sheet
Executive Summary
FINANCIAL DISCLOSURE THRESHOLD FOR CLINICAL INVESTIGATORS RAISED TO $25,000 in a final rule published by FDA in the Feb. 2 Federal Register. In its 1994 proposal, the agency had suggested a significantly lower trigger of $5,000 ("The Gray Sheet" Sept. 26, 1994, p. 12).